6pm registration for a 6.30pm start | 1 CPD Point
Reflections/lessons learnt from Monckton Counsel acting in the seminal EU/UK cases: Pfizer/Flynn and the blockbuster ‘pay for delay’ cases of Lundbeck, Servier and Paroxetine
Chair: Josh Holmes QC
Mark Brealey QC and Ronit Kreisberger
- The role of benchmarks in the analysis of excessive prices – for drugs and generally
- Significance of the AG Wahl Opinion / Judgment in the Latvian copyright society case
- The antitrust regulator’s approach to testing prices
- Deploying evidence on prices in the CAT
- Competition law as a tool to plug a regulatory lacuna
- Proving one’s case in the CAT: the “pay for delay” experience, CAT procedure, and forensic tactics
- Defining the market in the context of suspected abuse of dominance by pharma companies
- Where are we now? Lundbeck, Servier and, now, Paroxetine in the ECJ
This seminar is free to attend, to secure your place please click here.